Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 18

1.

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.

Lustig RH, Greenway F, Velasquez-Mieyer P, Heimburger D, Schumacher D, Smith D, Smith W, Soler N, Warsi G, Berg W, Maloney J, Benedetto J, Zhu W, Hohneker J.

Int J Obes (Lond). 2006 Feb;30(2):331-41.

2.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
3.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
4.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity.

O'Meara S, Riemsma R, Shirran L, Mather L, ter Riet G.

Health Technol Assess. 2001;5(18):1-81. Review.

5.

Efficacy of Olibra: a 12-week randomized controlled trial and a review of earlier studies.

Rebello CJ, Martin CK, Johnson WD, O'Neil CE, Greenway FL.

J Diabetes Sci Technol. 2012 May 1;6(3):695-708. Review.

6.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
7.

Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTs.

Chan EW, He Y, Chui CS, Wong AY, Lau WC, Wong IC.

Obes Rev. 2013 May;14(5):383-92. doi: 10.1111/obr.12015. Epub 2013 Jan 21. Review.

PMID:
23331711
8.

Lorcaserin: a review of its use in chronic weight management.

Hoy SM.

Drugs. 2013 Apr;73(5):463-73. doi: 10.1007/s40265-013-0035-1. Review.

PMID:
23529825
9.

Phentermine/topiramate for the treatment of obesity.

Smith SM, Meyer M, Trinkley KE.

Ann Pharmacother. 2013 Mar;47(3):340-9. Review.

PMID:
23482732
10.

[Effect of green tea or green tea extract consumption on body weight and body composition; systematic review and meta-analysis].

Baladia E, Basulto J, Manera M, Martínez R, Calbet D.

Nutr Hosp. 2014 Mar 1;29(3):479-90. doi: 10.3305/nh.2014.29.3.7118. Review. Spanish.

11.

Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: a systematic literature review.

Broder MS, Beenhouwer D, Strosberg JR, Neary MP, Cherepanov D.

World J Gastroenterol. 2015 Feb 14;21(6):1945-55. doi: 10.3748/wjg.v21.i6.1945. Review.

12.

Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review.

Davies-Vorbrodt S, Ito JI, Tegtmeier BR, Dadwal SS, Kriengkauykiat J.

Pharmacotherapy. 2013 Jan;33(1):22-30. doi: 10.1002/phar.1156. Review.

PMID:
23307541
13.

Weight Loss Pharmacotherapy: Brief Summary of the Clinical Literature and Comments on Racial Differences.

Egan BM, White K.

Ethn Dis. 2015 Nov 5;25(4):511-4. doi: 10.18865/ed.25.4.511. Review.

14.

Naltrexone ER/Bupropion ER: A Review in Obesity Management.

Greig SL, Keating GM.

Drugs. 2015 Jul;75(11):1269-80. doi: 10.1007/s40265-015-0427-5. Review.

PMID:
26105116
15.

Contemporary review of drugs used to treat obesity.

Patham B, Mukherjee D, San Juan ZT.

Cardiovasc Hematol Agents Med Chem. 2013 Dec;11(4):272-80. Review.

PMID:
24635048
16.
17.

What is the best size descriptor to use for pharmacokinetic studies in the obese?

Green B, Duffull SB.

Br J Clin Pharmacol. 2004 Aug;58(2):119-33. Review.

18.

A Review of the Efficacy and Safety of Litramine IQP-G-002AS, an Opuntia ficus-indica Derived Fiber for Weight Management.

Chong PW, Lau KZ, Gruenwald J, Uebelhack R.

Evid Based Complement Alternat Med. 2014;2014:943713. doi: 10.1155/2014/943713. Epub 2014 Aug 28. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk